Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

5.4K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.4K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

White matter hyperintensities are associated with locus coeruleus atrophy and astrocytic β<sub>2</sub>-adrenergic receptor expression.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Activities of daily living and their neural correlates across the Alzheimer's disease continuum: Evidence from a Latin American cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Global neural oscillations underlie performance variability and attentional state fluctuations in humans.

Scientific reports·2026
Same author

The emergence of the modern human Mind: Inner speech and its link to memory mechanisms.

Brain research·2026
Same author

A comprehensive multimodal MRI and EEG-TMS dataset on the impact of parietal cortex inhibition on decision-making under ambiguity.

Data in brief·2026
Same author

Aperiodic Exponent of Brain Field Potentials Is Dependent on the Frequency Range It Is Estimated.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2025

Related Experiment Video

Updated: May 1, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.7K

Irrelevant stimulus processing in ADHD: catecholamine dynamics and attentional networks.

Francisco Aboitiz1, Tomás Ossandón1, Francisco Zamorano2

  • 1Department of Psychiatry, Medical School, Centro Interdisciplinario de Neurociencia, Pontificia Universidad Católica de Chile Santiago, Chile.

Frontiers in Psychology
|April 12, 2014
PubMed
Summary

Attention deficit and hyperactivity disorder (ADHD) involves distractibility due to imbalances in brain networks. This research links catecholamine signaling dynamics to attentional network dysfunction, offering insights for ADHD treatment.

Keywords:
CNVP300attentionfMRIventral attentional network

More Related Videos

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

9.7K
Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control
09:37

Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control

Published on: July 5, 2015

8.8K

Related Experiment Videos

Last Updated: May 1, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.7K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

9.7K
Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control
09:37

Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control

Published on: July 5, 2015

8.8K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Science

Background:

  • Attention deficit and hyperactivity disorder (ADHD) is characterized by distractibility, linked to dopaminergic signaling deficits in cortico-striatal networks.
  • Impaired large-scale brain networks, including task-positive networks, default mode network (DMN), ventral attentional network (VAN), and salience network (SN), are implicated in ADHD.

Purpose of the Study:

  • To explore the relationship between tonic-phasic catecholaminergic signaling dynamics and the activity of large-scale cortical networks involved in behavioral regulation.
  • To propose a model where catecholamine imbalance contributes to distractibility and executive function deficits in ADHD.

Main Methods:

  • Review of evidence from pharmacology, brain imaging, and electrophysiology studies.
  • Discussion of tonic-phasic catecholamine signaling and its impact on brain network activity.

Main Results:

  • A proposed mechanism suggests that imbalanced tonic catecholamine levels during tasks enhance phasic signaling and VAN excitability, leading to distractibility.
  • Immature SN function, potentially due to abnormal tonic signaling, may impair executive system development in ADHD.

Conclusions:

  • Restoring catecholamine signaling pharmacodynamics is crucial for alleviating ADHD symptoms.
  • Cognitive rehabilitation strategies may offer a complementary approach to modulate network dynamics and compensate for pharmacological deficits.